Capex / revenue moved 183 bp lower
Capex / revenue changed -183 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.15%→0.32%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MANH financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 953 bp lower
Free-cash-flow margin changed -953 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
31.61%→22.08%2 prior comparisons
Operating cash-flow margin moved 1136 bp lower
Operating cash-flow margin changed -1136 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
33.76%→22.40%2 prior comparisons
Revenue increased 11.0%
Revenue changed +11.0% from the comparable as-filed period.
$275.8M→$306.2M2 prior comparisons
Receivables / revenue moved 796 bp higher
Receivables / revenue changed +796 basis points from the comparable as-filed period.
79.61%→87.56%2 prior comparisons
Operating income increased 6.8%
Operating income changed +6.8% from the comparable as-filed period.
$75.8M→$81.0M2 prior comparisons
Stock-based compensation increased 24.1%
Stock-based compensation changed +24.1% from the comparable as-filed period.
$27.6M→$34.2M2 prior comparisons
Gross margin moved 37 bp higher
Gross margin changed +37 basis points from the comparable as-filed period.
56.56%→56.93%2 prior comparisons
Operating cash flow / net income decreased 29.6%
Operating cash flow / net income changed -29.6% from the comparable as-filed period.
1.59→1.122 prior comparisons
SBC / revenue moved 118 bp higher
SBC / revenue changed +118 basis points from the comparable as-filed period.
10.00%→11.17%2 prior comparisons
Net income increased 4.6%
Net income changed +4.6% from the comparable as-filed period.
$58.6M→$61.3M2 prior comparisons
Cost of revenue increased 10.1%
Cost of revenue changed +10.1% from the comparable as-filed period.
$119.8M→$131.9M2 prior comparisons
Research & development decreased 2.2%
Research & development changed -2.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$36.4M→$35.5M2 prior comparisons
R&D / revenue moved 158 bp lower
R&D / revenue changed -158 basis points from the comparable as-filed period.
13.18%→11.61%2 prior comparisons
Total assets decreased 2.3%
Total assets changed -2.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$768.8M→$750.8M4 prior comparisons
Current assets decreased 2.4%
Current assets changed -2.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$525.8M→$512.9M4 prior comparisons
Operating income decreased 10.2%
Operating income changed -10.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$73.8M→$66.2M2 prior comparisons
Receivables / revenue moved 353 bp lower
Receivables / revenue changed -353 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
77.03%→73.50%2 prior comparisons
Gross margin moved 81 bp lower
Gross margin changed -81 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
57.34%→56.53%2 prior comparisons
Revenue increased 9.3%
Revenue changed +9.3% from the comparable as-filed period.
$272.4M→$297.8M2 prior comparisons
Free-cash-flow margin moved 439 bp higher
Free-cash-flow margin changed +439 basis points from the comparable as-filed period.
25.72%→30.11%2 prior comparisons
Operating cash-flow margin moved 327 bp higher
Operating cash-flow margin changed +327 basis points from the comparable as-filed period.
27.18%→30.45%2 prior comparisons
Net income decreased 11.3%
Net income changed -11.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$56.8M→$50.4M2 prior comparisons
Operating cash flow / net income increased 38.1%
Operating cash flow / net income changed +38.1% from the comparable as-filed period.
1.3→1.82 prior comparisons
Capex / revenue moved 112 bp lower
Capex / revenue changed -112 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.46%→0.34%2 prior comparisons
Total assets decreased 6.2%
Total assets changed -6.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$744.7M→$698.6M4 prior comparisons
Stock-based compensation increased 20.9%
Stock-based compensation changed +20.9% from the comparable as-filed period.
$24.3M→$29.4M3 prior comparisons
SBC / revenue moved 95 bp higher
SBC / revenue changed +95 basis points from the comparable as-filed period.
8.91%→9.86%2 prior comparisons
Current assets decreased 3.4%
Current assets changed -3.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$483.3M→$467.1M4 prior comparisons
Cost of revenue increased 11.4%
Cost of revenue changed +11.4% from the comparable as-filed period.
$116.2M→$129.5M2 prior comparisons
Trade receivables increased 4.3%
Trade receivables changed +4.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$209.8M→$218.9M4 prior comparisons
Research & development decreased 0.3%
Research & development changed -0.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$34.9M→$34.8M2 prior comparisons
R&D / revenue moved 113 bp lower
R&D / revenue changed -113 basis points from the comparable as-filed period.
12.80%→11.67%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.